These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

461 related items for PubMed ID: 33743082

  • 1. Continuous glucose monitoring in patients with type 2 diabetes on hemodialysis.
    Gallieni M, De Salvo C, Lunati ME, Rossi A, D'Addio F, Pastore I, Sabiu G, Miglio R, Zuccotti GV, Fiorina P.
    Acta Diabetol; 2021 Aug; 58(8):975-981. PubMed ID: 33743082
    [Abstract] [Full Text] [Related]

  • 2. Assessment of markers of glycaemic control in diabetic patients with chronic kidney disease using continuous glucose monitoring.
    Vos FE, Schollum JB, Coulter CV, Manning PJ, Duffull SB, Walker RJ.
    Nephrology (Carlton); 2012 Feb; 17(2):182-8. PubMed ID: 21883672
    [Abstract] [Full Text] [Related]

  • 3. Comparison of Glycemic Markers in Chronic Hemodialysis Using Continuous Glucose Monitoring.
    Divani M, Georgianos PI, Didangelos T, Iliadis F, Makedou A, Hatzitolios A, Liakopoulos V, Grekas DM.
    Am J Nephrol; 2018 Feb; 47(1):21-29. PubMed ID: 29275415
    [Abstract] [Full Text] [Related]

  • 4. Continuous Glucose Monitoring and Use of Alternative Markers To Assess Glycemia in Chronic Kidney Disease.
    Zelnick LR, Batacchi ZO, Ahmad I, Dighe A, Little RR, Trence DL, Hirsch IB, de Boer IH.
    Diabetes Care; 2020 Oct; 43(10):2379-2387. PubMed ID: 32788282
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Critical discrepancy in blood glucose control levels evaluated by glycated albumin and estimated hemoglobin A1c levels determined from a flash continuous glucose monitoring system in patients with type 2 diabetes on hemodialysis.
    Ushigome E, Matsusaki S, Watanabe N, Hashimoto T, Nakamura N, Fukui M.
    J Diabetes Investig; 2020 Nov; 11(6):1570-1574. PubMed ID: 32356596
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Response to Comment on Kaminski et al. Assessment of Glycemic Control by Continuous Glucose Monitoring, Hemoglobin A1c, Fructosamine, and Glycated Albumin in Patients With End-Stage Kidney Disease and Burnt-Out Diabetes. Diabetes Care 2024;47:267-271.
    Vellanki P, Umpierrez GE.
    Diabetes Care; 2024 Aug 01; 47(8):e63-e64. PubMed ID: 39052906
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Blood glucose fluctuations in hemodialysis patients with end stage diabetic nephropathy.
    Jin YP, Su XF, Yin GP, Xu XH, Lou JZ, Chen JJ, Zhou Y, Lan J, Jiang B, Li Z, Lee KO, Ye L, Ma JH.
    J Diabetes Complications; 2015 Apr 01; 29(3):395-9. PubMed ID: 25681043
    [Abstract] [Full Text] [Related]

  • 11. Assessment of Glycemic Control by Continuous Glucose Monitoring, Hemoglobin A1c, Fructosamine, and Glycated Albumin in Patients With End-Stage Kidney Disease and Burnt-Out Diabetes.
    Kaminski CY, Galindo RJ, Navarrete JE, Zabala Z, Moazzami B, Gerges A, McCoy RG, Fayfman M, Vellanki P, Idrees T, Peng L, Umpierrez GE.
    Diabetes Care; 2024 Feb 01; 47(2):267-271. PubMed ID: 38085705
    [Abstract] [Full Text] [Related]

  • 12. Significant inverse relationship between serum undercarboxylated osteocalcin and glycemic control in maintenance hemodialysis patients.
    Okuno S, Ishimura E, Tsuboniwa N, Norimine K, Yamakawa K, Yamakawa T, Shoji S, Mori K, Nishizawa Y, Inaba M.
    Osteoporos Int; 2013 Feb 01; 24(2):605-12. PubMed ID: 22581293
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Use of complementary markers in assessing glycaemic control in people with diabetic kidney disease undergoing iron or erythropoietin treatment.
    Konya J, Ng JM, Cox H, Cooke M, Lewis N, Bhandari S, Atkin SL, Kilpatrick ES.
    Diabet Med; 2013 Oct 01; 30(10):1250-4. PubMed ID: 23758176
    [Abstract] [Full Text] [Related]

  • 18. Glycated albumin in diabetic patients with chronic kidney disease.
    Zheng CM, Ma WY, Wu CC, Lu KC.
    Clin Chim Acta; 2012 Oct 09; 413(19-20):1555-61. PubMed ID: 22579765
    [Abstract] [Full Text] [Related]

  • 19. Serum glycated albumin predicts all-cause mortality in dialysis patients with diabetes mellitus: meta-analysis and systematic review of a predictive biomarker.
    Copur S, Siriopol D, Afsar B, Comert MC, Uzunkopru G, Sag AA, Ortiz A, Covic A, van Raalte DH, Cherney DZ, Rossing P, Kanbay M.
    Acta Diabetol; 2021 Jan 09; 58(1):81-91. PubMed ID: 32862262
    [Abstract] [Full Text] [Related]

  • 20. Distinct biomarker roles for HbA1c and glycated albumin in patients with type 2 diabetes on hemodialysis.
    Hayashi A, Takano K, Masaki T, Yoshino S, Ogawa A, Shichiri M.
    J Diabetes Complications; 2016 Jan 09; 30(8):1494-1499. PubMed ID: 27614726
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.